Wednesday, 3 October 2012

Boots Pain Relief heat Spray





1. Name Of The Medicinal Product



Pain Relief Warming Spray or Warming Pain Relief Spray or Boots Pain Relief Heat Spray


2. Qualitative And Quantitative Composition












Active ingredients




 



 




Ethyl nicotinate




1.1% w/w




Methyl salicylate




1.25% w/w




Racemic camphor




0.625% w/w



3. Pharmaceutical Form



Topical spray.



4. Clinical Particulars



4.1 Therapeutic Indications



For the relief of muscular and rheumatic pains, lumbago, fibrositis, sciatica, sprains, strains and stiffness.



For topical administration.



4.2 Posology And Method Of Administration



Adults and children over 5 years: Spray the site of pain using 2 or 3 short bursts, holding the container about 6 inches (15cm) from the skin.



Children under 5 years: Not to be used by children under 5 years.



Elderly: The normal adult dose is still appropriate in the elderly.



4.3 Contraindications



Hypersensitivity to any of the ingredients.



Children under 5 years.



4.4 Special Warnings And Precautions For Use



For external use only.



Use sparingly as over-application can cause discomfort.



Discontinue use of the product if excessive irritation occurs.



Keep away from the eyes, face, mucous membranes and other sensitive parts of the body.



Do not use on broken or damaged skin or on open cuts.



If symptoms persist, consult your doctor.



Avoid inhalation.



Keep all medicines out of the reach of children.



4.5 Interaction With Other Medicinal Products And Other Forms Of Interaction



No clinically significant drug interactions known.



4.6 Pregnancy And Lactation



Although there are no data available to support the use of this product during pregnancy and lactation it is unlikely that use of this product would constitute a hazard to the foetus or breast fed infant.



4.7 Effects On Ability To Drive And Use Machines



No adverse effect known.



4.8 Undesirable Effects



Occasional hypersensitivity reactions.



4.9 Overdose



It is unlikely that overdosage will occur, but in the event, symptomatic treatment only should be sufficient.



5. Pharmacological Properties



5.1 Pharmacodynamic Properties



Methyl salicylate has local analgesic and counter irritant properties.



Ethyl nicotinate has vasodilator properties and produces rubefacient activity.



Camphor acts as a mild analgesic, rubefacient and counter irritant.



5.2 Pharmacokinetic Properties



None stated.



5.3 Preclinical Safety Data



There are no preclinical data of relevance to the prescriber which are additional to that already included in other sections of the SPC.



6. Pharmaceutical Particulars



6.1 List Of Excipients



Denatured ethanol



Hydrocarbon 40



6.2 Incompatibilities



Not applicable



6.3 Shelf Life



36 months



6.4 Special Precautions For Storage



Pressurised container:



Protect from sunlight; do not expose to temperatures above 50EC; do not pierce or burn even when empty.



6.5 Nature And Contents Of Container



A tinplate internally lacquered aerosol can, having an aervalve and a white/black polypropylene actuator spray fitted with a polyethylene or polypropylene cover.



Pack size: 125ml



6.6 Special Precautions For Disposal And Other Handling



Do not spray on a naked flame or any incandescent material. Do not use near, and do not place container on, polished or painted surfaces.



7. Marketing Authorisation Holder



The Boots Company PLC



Nottingham



NG2 3AA



8. Marketing Authorisation Number(S)



PL 00014/0275



9. Date Of First Authorisation/Renewal Of The Authorisation



19 July 1982 / 7 December 2002



10. Date Of Revision Of The Text



March 2004




No comments:

Post a Comment